FLASH Radiotherapy Research with Stanford's Dr. Bill Loo
Join Thomas Braun for a discussion with Dr. Bill Loo, a radiation oncologist and researcher at Stanford University, about ongoing research into FLASH radiotherapy — an experimental ultra-high-dose-rate approach to radiation therapy.
Dr. Loo explains the science behind delivering radiation in a fraction of a second, early studies on its potential to reduce side effects on healthy tissue while maintaining effectiveness against tumors, and work on compact accelerator technology from Stanford/SLAC being developed by TibaRay.
Important note: FLASH radiotherapy is still in the research and early clinical development stage. It is not currently an approved standard treatment. This video is for informational and educational purposes only and does not constitute medical advice. Always consult your physician and follow guidance from qualified healthcare professionals for cancer treatment decisions.
Topics include motion management in radiotherapy, the 'FLASH effect' observed in preclinical studies, and implications for future cancer care.
#Radiotherapy #CancerResearch #StanfordMedicine #MedicalInnovation #FLASHRadiotherapy
Bill Loo is a physician-scientist Radiation Oncologist and Bioengineer, and Professor of Radiation Oncology at Stanford University School of Medicine. He serves as Director of Thoracic Radiation Oncology, Co-Director of Particle Therapy, and Director of New Technologies in Radiation Oncology at Stanford Cancer Institute. His clinical expertise is in state-of-the-art radiation therapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and 4-D image-guided radiation therapy.
He is an internationally recognized expert on thoracic cancers and radiotherapy and serves on expert panels of the National Comprehensive Cancer Network that produce among the most widely adopted clinical practice guidelines for cancer. His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer and development of new medical imaging and other biomarkers. He is principal investigator of a research lab recognized as a global leader in the biology of ultra-rapid FLASH radiotherapy and development of next generation radiation technologies to deliver FLASH.
Bill conceived of the revolutionary PHASER concept for highly conformal FLASH cancer therapy and serves as co-leader of its research and development. He is a co-founder, board member, and Chief Medical Advisor of TibaRay where this technology is being brought to practical reality.
Bill received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Onc…Read More